The iconic rise of Viagra has long been a example of pharmaceutical success, yet its future within the broader sector now triggers questions about long-term yields . Alternative versions are diminishing exclusivity , prompting worries that betting on companies significantly dependent to Viagra's former influence could be a speculative move , especi